Incidence and Pattern of Overactive Bladder Symptoms Occurring After Hysterectomy
Data Collection
Collected from today forward - ProspectiveCohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: September 1, 2012
Actual date on which the first participant was enrolled.To evaluate the incidence and pattern of bladder symptoms and sexual function change occuring after simple hysterectomy and to analyze the influence of bladder symptoms and sexual function change on quality of life of patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.300 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 20 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: Patients who is planed to undergo simple hysterectomy due to benign uterine disease Uterine leiomyoma Uterine adenomyosis Endometrial hyperplasia Cervical intraepithelial neoplasia (including carcinoma in situ, FIGO stage IA1 cancer) Dysfunctional uterine bleeding Other benign uterine disease requiring hysterectomy Exclusion Criteria: Patients who are taking medication for overactive bladder Patients who underwent incontinence surgery due to urinary incontinence Acute or chronic infectious disease of urinary tract Neurologic disease causing urinary abnormality Previous pelvic radiation therapy Patients who are undergoing incontinence surgery with hysterectomy Pregnant woman
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center
Seoul, South KoreaOpen Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center in Google Maps